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1The use of noninvasive cardiac imaging to detect heart disease to guide therapy has grown substantially during 
the past decade. To date, imaging tests using ultrasound or 
magnetic fields have been perceived as safer alternatives com-
pared with well-established and widely used tests, which use 
ionizing radiation such as computed tomography and nuclear 
imaging. For the latter, many efforts have been done to reduce 
radiation exposure to the patients and despite substantial 
advancements even more efforts will be needed to further 
reduce radiation exposure.1,2
See Article by Lancellotti et al
By using a static and a gradient magnetic field in combi-
nation with a radiofrequency field, magnetic resonance (MR) 
provides excellent contrast among different tissues of the 
body, including the brain, the musculoskeletal system, and 
the heart. Cardiac MR (CMR) imaging has evolved from a 
premature technique into a tool with the potential to find an 
important clinical role in the near future for the noninvasive 
assessment of morphological and functional aspects of the 
heart. Consequently, CMR belongs to the fastest growing 
new fields of broad MR application. At the same time, CMR 
uses some of the strongest and fastest switching electromag-
netic gradients available in MR imaging.3,4 The amount of 
radiofrequency field energy delivered is defined as the spe-
cific absorption rate. Although long-term effects on human 
health from exposure to strong static magnetic fields seem 
unlikely,5 acute effects such as vertigo, nausea, change in 
blood pressure, reversible arrhythmia,6 and neurobehavioral 
effects have been documented from occupational exposure 
to 1.5 T.7 Studies focusing on experimental teratogenic8–12 
or carcinogenic13–15 effects of MR have demonstrated con-
flicting results. However, recently concerns about potential 
genotoxic effects of MR imaging have been raised.16,17 On 
the basis of a growing body of literature showing in vitro and 
in vivo3,16,18 data supporting both exposure time-dependent 
as well as dose-related effects of magnetic fields on DNA 
integrity, the International Agency for Research on Cancer 
(IARC) has classified (extremely low) gradient fields gen-
erated during MR scanning as possible human carcinogen 
(group 2B).19 Similarly, the European Parliament20 as well 
as the International Commission on Non-Ionizing Radiation 
Protection (ICNIRP)21 and the World Health Organization 
(WHO)22 have urgently called for an action to evaluate 
adverse biological effects of clinical MR scanning.
In fact, several laboratories have independently and con-
sistently observed an increase in DNA double-strand breaks 
(DSBs) after CMR scanning by the use of a broad spectrum 
of methods, such as histone γ-H2AX phosphorylation, comet 
assay, or micronuclei.3,23–25 However, although Simi et al3 
have reported on persistence of DSB ≤24 hours after CMR 
exposure, most other studies did not address the persistence 
of the DSB induced by CMR, although this is a key issue of 
genetic risk assessment as DNA damage can trigger DNA 
instability and exert potential carcinogenic effects. It is in this 
context that Lancellotti et al,26 in this issue of Circulation: 
Cardiovascular Imaging, have studied an important aspect of 
the impact of CMR scanning on peripheral lymphocyte DNA 
integrity, namely the time course over 1 year. Their results 
are remarkable for several reasons. First, they studied CMR 
alone with no gadolinium-based contrast medium to avoid 
confounding effects from the genotoxic contrast medium. As 
the latter, however, is widely used off-label in the vast major-
ity of clinical CMR scans,27 the findings may be even more 
relevant in the clinical setting. Second, they did not find any 
DNA damage early after CMR but observed an increase in 
DSB from day 2 until the first month, which disappeared after 
1 year. Third, they found that CMR was also associated with 
a minor but significant immediate blood cell alteration reflect-
ing inflammatory response. This adds a new aspect to the 
knowledge of biological reactions to CMR exposure.
Several putative mechanisms by which MR may increase 
DSB have been published, mainly focusing on impairment 
of repair mechanisms, for example by activation of oxidative 
stress pathways28 or initiation of transcription by interact-
ing with moving electrons in DNA by generating repulsive 
(Lorentz) forces causing chain separation at specific DNA 
sequences.29 As opposed to ionizing radiation with direct dam-
age to the DNA, the impairment of repair mechanisms may 
require more time before an increase in DSB can be measured. 
This would support why the authors found a delay between 
CMR exposure and DNA damage. The authors suggest that 
previous studies had found a somewhat earlier increase in 
DSB because patients were also exposed to gadolinium,3,23 
which has been shown to potentiate the genotoxic effect of 
CMR30 but still requires some delay after CMR exposure. 
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According to this delay hypothesis, immediate post-CMR 
measurements would not detect DNA damage. This fits well 
with recent results by Brand et al31 who failed to detect DSB 
induction as early as 5 minutes after CMR exposure.
Another key finding in the study by Lancellotti et al,26 
which supports a causal relationship between DNA damage 
and CMR is the strong and impressive correlation between 
the augmentation of γ-H2AX levels at 1 month and the spe-
cific absorption rate values. This dose–response relation in the 
clinical setting was the final missing link closing the causal 
gap of knowledge about DSB induction and CMR scanning.
Despite the important information provided by the study 
of Lancellotti et al,26 many questions remain unanswered. As 
the vast majority of CMR scans involve gadolinium-based 
contrast application more information on the interaction of 
gadolinium with CMR with regard to DNA damage and its 
time course would be of great clinical interest. Moreover, 
with the available data one cannot comment on the long-term 
clinical impact of the DNA damage caused by nonionizing 
radiation and it is foreseeable that such information will most 
probably be difficult to acquire. Even for ionizing radiation 
from diagnostic procedures, no direct observational proof 
of its adverse impact on outcome is available because of the 
small scale of damage and the long delay between exposure 
and event. Estimations of the increased risk of cancer after 
low-dose radiation are based on extrapolations from popu-
lation cohorts exposed to larger radiation doses,16 such as 
atomic bomb survivors (who were also exposed to a nuclear 
electromagnetic pulse). Although the results by Lancellotti et 
al26 may not answer all questions, they do increase the aware-
ness of potential hazards of CMR. We need to be aware of the 
potential association of any type of radiation (ionizing or non-
ionizing) with cancer32 because one cannot predict the risk in 
individual patients, and because clinically significant conse-
quences may not become evident for many years. That is why 
the authors suggest applying the precautionary principle also 
to CMR, concurring with other experts.33 Increased awareness 
of this potential association should stimulate more research so 
that the medical and imaging community can fully understand 
the biological effects of nuclear MR imaging.
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